Loading...
A Case of Severe Acute Respiratory Syndrome Coronavirus 2 Treatment With Remdesivir in a Hepatitis C-Coinfected Patient Resulting in Temporary Viral Control and Posttreatment Flare
We report a case of a man with chronic hepatitis C infection treated with remdesivir for COVID-19, resulting in lowered HCV viral load, followed by a rebound after its discontinuation. Concomitant treatment with tocilizumab possibly caused loss of anti-HBs.
Saved in:
| Published in: | Open Forum Infect Dis |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Oxford University Press
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7989155/ https://ncbi.nlm.nih.gov/pubmed/33880393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofab100 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|